UPL [UPL] vs Bayer CropScience [BAYERCROP] Detailed Stock Comparison
UPL
NSE
Loading...
Bayer CropScience
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: UPL wins in 9 metrics, Bayer CropScience wins in 11 metrics, with 0 ties. Bayer CropScience appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | UPL | Bayer CropScience | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 50.50 | 41.95 | Bayer CropScience |
| Price-to-Book Ratio | 1.98 | 8.71 | UPL |
| Debt-to-Equity Ratio | 66.35 | 3.69 | Bayer CropScience |
| PEG Ratio | -0.77 | 4.35 | UPL |
| EV/EBITDA | 11.81 | 36.64 | UPL |
| Profit Margin (TTM) | 2.55% | 10.29% | Bayer CropScience |
| Operating Margin (TTM) | 6.21% | 16.78% | Bayer CropScience |
| EBITDA Margin (TTM) | 6.21% | 16.78% | Bayer CropScience |
| Return on Equity | 2.01% | 19.93% | Bayer CropScience |
| Return on Assets (TTM) | 0.86% | 10.83% | Bayer CropScience |
| Free Cash Flow (TTM) | $84.56B | $2.21B | UPL |
| Dividend Yield | 1.07% | 2.20% | Bayer CropScience |
| 1-Year Return | 23.29% | -11.22% | UPL |
| Price-to-Sales Ratio (TTM) | 1.20 | 4.32 | UPL |
| Enterprise Value | $786.44B | $245.74B | UPL |
| EV/Revenue Ratio | 1.68 | 4.27 | UPL |
| Gross Profit Margin (TTM) | 54.76% | 38.86% | UPL |
| Revenue per Share (TTM) | $651 | $1,281 | Bayer CropScience |
| Earnings per Share (Diluted) | $13.54 | $131.63 | Bayer CropScience |
| Beta (Stock Volatility) | 0.65 | 0.32 | Bayer CropScience |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
UPL vs Bayer CropScience Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| UPL | 0.87% | 2.71% | -0.90% | 9.57% | 8.81% | 41.32% |
| Bayer CropScience | 0.29% | -1.38% | -11.51% | 9.53% | 17.49% | 0.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| UPL | 23.29% | -6.93% | 36.22% | 103.35% | 476.31% | 1,006.54% |
| Bayer CropScience | -11.22% | 4.27% | -7.54% | 43.01% | 434.74% | 901.08% |
Performance & Financial Health Analysis: UPL vs Bayer CropScience
| Metric | UPL | BAYERCROP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹562.07B | ₹248.42B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 3,203,478 | 50,719 |
| 90 Day Avg. Volume | 2,845,688 | 38,529 |
| Last Close | ₹713.45 | ₹5,580.00 |
| 52 Week Range | ₹493.00 - ₹735.85 | ₹4,217.45 - ₹6,919.60 |
| % from 52W High | -3.04% | -19.36% |
| All-Time High | ₹864.70 (Jun 07, 2021) | ₹7,196.85 (Aug 05, 2024) |
| % from All-Time High | -17.49% | -22.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.17% |
| Quarterly Earnings Growth | 0.02% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.10% |
| Operating Margin (TTM) | 0.06% | 0.17% |
| Return on Equity (TTM) | 0.02% | 0.20% |
| Debt to Equity (MRQ) | 66.35 | 3.69 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹345.95 | ₹634.24 |
| Cash per Share (MRQ) | ₹116.29 | ₹204.91 |
| Operating Cash Flow (TTM) | ₹70.93B | ₹-2,277,000,000 |
| Levered Free Cash Flow (TTM) | ₹7.59B | ₹5.68B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.07% | 2.20% |
| Last 12-Month Dividend | ₹6.96 | ₹125.00 |
Valuation & Enterprise Metrics Analysis: UPL vs Bayer CropScience
| Metric | UPL | BAYERCROP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 50.50 | 41.95 |
| Forward P/E | 14.26 | 28.64 |
| PEG Ratio | -0.77 | 4.35 |
| Price to Sales (TTM) | 1.20 | 4.32 |
| Price to Book (MRQ) | 1.98 | 8.71 |
| Market Capitalization | ||
| Market Capitalization | ₹562.07B | ₹248.42B |
| Enterprise Value | ₹786.44B | ₹245.74B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.68 | 4.27 |
| Enterprise to EBITDA | 11.81 | 36.64 |
| Risk & Other Metrics | ||
| Beta | 0.65 | 0.32 |
| Book Value per Share (MRQ) | ₹345.95 | ₹634.24 |
Financial Statements Comparison: UPL vs Bayer CropScience
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UPL | BAYERCROP |
|---|---|---|
| Revenue/Sales | ₹92.16B | ₹19.15B |
| Cost of Goods Sold | ₹41.69B | ₹11.71B |
| Gross Profit | ₹50.47B | ₹7.44B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹7.64B | ₹3.21B |
| EBITDA | ₹14.78B | ₹3.67B |
| Pre-Tax Income | ₹-1.90B | ₹3.35B |
| Income Tax | ₹-140.00M | ₹565.00M |
| Net Income (Profit) | ₹-1.76B | ₹2.79B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UPL | BAYERCROP |
|---|---|---|
| Cash & Equivalents | ₹94.78B | ₹8.86B |
| Total Current Assets | ₹396.61B | ₹44.72B |
| Total Current Liabilities | ₹285.69B | ₹22.24B |
| Long-Term Debt | ₹192.56B | ₹616.00M |
| Total Shareholders Equity | ₹378.26B | ₹28.50B |
| Retained Earnings | ₹208.68B | ₹23.08B |
| Property, Plant & Equipment | ₹94.31B | ₹902.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UPL | BAYERCROP |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | UPL | BAYERCROP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,203,478 | 50,719 |
| Average Daily Volume (90 Day) | 2,845,688 | 38,529 |
| Shares Outstanding | 844.43M | 44.94M |
| Float Shares | 612.60M | 19.00M |
| % Held by Insiders | 0.38% | 0.73% |
| % Held by Institutions | 0.41% | 0.12% |
Dividend Analysis & Yield Comparison: UPL vs Bayer CropScience
| Metric | UPL | BAYERCROP |
|---|---|---|
| Last 12-Month Dividend | ₹6.96 | ₹125.00 |
| Last 12-Month Dividend Yield | 1.07% | 2.20% |
| 3-Year Avg Annual Dividend | ₹5.52 | ₹141.67 |
| 3-Year Avg Dividend Yield | 0.79% | 1.16% |
| 3-Year Total Dividends | ₹16.55 | ₹425.00 |
| Ex-Dividend Date | Jul 11, 2025 | Aug 07, 2025 |